Dr Absar Khalid Mir et al. 2024. EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY. Journal of Population Therapeutics and Clinical Pharmacology. 31, 6 (Jun. 2024), 1059–1065. DOI:https://doi.org/10.53555/jptcp.v31i6.6611.